Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: Propensity score analysis

2008 ◽  
Vol 72 (1) ◽  
pp. 7-12 ◽  
Author(s):  
Robert J. Applegate ◽  
Matthew Sacrinty ◽  
Michael Kutcher ◽  
Renato Santos ◽  
Sanjay Gandhi ◽  
...  
Keyword(s):  
Propensity Score ◽  
Saphenous Vein ◽  
Propensity Score Analysis ◽  
Bare Metal Stents ◽  
Metal Stents ◽  
Bare Metal ◽  
Vein Grafts ◽  
Saphenous Vein Grafts ◽  
Score Analysis ◽  
Drug Eluting

Safety and efficacy of drug-eluting stents versus bare-metal stents in saphenous vein grafts lesions: a meta-analysis

2010 ◽  
Vol 6 (1) ◽  
pp. 149-160 ◽  
Author(s):  
Angel Sanchez-Recalde ◽  
Santiago Jiménez Valero ◽  
Raul Moreno ◽  
Laura Barreales ◽  
Íñigo Lozano ◽  
...  
Keyword(s):  
Saphenous Vein ◽  
Meta Analysis ◽  
Bare Metal Stents ◽  
Drug Eluting Stents ◽  
Metal Stents ◽  
Bare Metal ◽  
Safety And Efficacy ◽  
Vein Grafts ◽  
Saphenous Vein Grafts ◽  
Drug Eluting

Comparison of Drug-Eluting and Bare Metal Stents in Saphenous Vein Grafts. Immediate and Long-Term Results

2009 ◽  
Vol 62 (1) ◽  
pp. 39-47 ◽  
Author(s):  
Íñigo Lozano ◽  
Tamara García-Camarero ◽  
Pilar Carrillo ◽  
José A. Baz ◽  
José M. de la Torre ◽  
...  
Keyword(s):  
Saphenous Vein ◽  
Bare Metal Stents ◽  
Long Term Results ◽  
Metal Stents ◽  
Bare Metal ◽  
Vein Grafts ◽  
Saphenous Vein Grafts ◽  
Drug Eluting

Drug-Eluting Stents Versus Bare Metal Stents for Narrowing in Saphenous Vein Grafts

2008 ◽  
Vol 102 (5) ◽  
pp. 530-534 ◽  
Author(s):  
Teruo Okabe ◽  
Joseph Lindsay ◽  
Ashesh N. Buch ◽  
Daniel H. Steinberg ◽  
Probal Roy ◽  
...  
Keyword(s):  
Saphenous Vein ◽  
Bare Metal Stents ◽  
Drug Eluting Stents ◽  
Metal Stents ◽  
Bare Metal ◽  
Vein Grafts ◽  
Saphenous Vein Grafts ◽  
Drug Eluting

Drug-Eluting Stents Versus Bare-Metal Stents for Saphenous Vein Grafts Lesions

2019 ◽  
Vol 28 ◽  
pp. S67
Author(s):  
S. Conte ◽  
D. Florisson ◽  
J. Debono ◽  
P. Vale
Keyword(s):  
Saphenous Vein ◽  
Bare Metal Stents ◽  
Drug Eluting Stents ◽  
Metal Stents ◽  
Bare Metal ◽  
Vein Grafts ◽  
Saphenous Vein Grafts ◽  
Drug Eluting

Long-term safety and efficacy of drug-eluting and bare metal stents in saphenous vein grafts

2012 ◽  
Vol 164 (1) ◽  
pp. 87-93 ◽  
Author(s):  
Ole Fröbert ◽  
Fredrik Scherstén ◽  
Stefan K. James ◽  
Jörg Carlsson ◽  
Bo Lagerqvist
Keyword(s):  
Saphenous Vein ◽  
Bare Metal Stents ◽  
Metal Stents ◽  
Bare Metal ◽  
Safety And Efficacy ◽  
Vein Grafts ◽  
Saphenous Vein Grafts ◽  
Drug Eluting

Drug-eluting versus bare metal stents in saphenous vein grafts compared to native coronary vessels. The NORSTENT study.

Cardiology ◽  
2021 ◽  
Author(s):  
Per Morten Mølstad ◽  
Jan Erik Nordrehaug ◽  
Terje K. Steigen ◽  
Tom Wilsgaard ◽  
Rune Wiseth ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Saphenous Vein ◽  
Bare Metal Stents ◽  
High Rate ◽  
Metal Stents ◽  
Bare Metal ◽  
Vein Grafts ◽  
Saphenous Vein Grafts ◽  
Stent Type ◽  
Drug Eluting

Abstract. Background. Drug-eluting stents (DES) reduce target lesion revascularization (TLR) with no effect on mortality or myocardial infarction (MI) compared to bare metal stents (BMS) in native vessels. Randomized stent studies in saphenous vein grafts (SVG) are few and the reported effects are ambiguous. The NORSTENT study is the first to randomize lesions to percutaneous coronary intervention (PCI) in native vessels and SVG. Aims. To compare rate of mortality, MI and TLR across stent and vessel types. Methods. In this substudy 6087 patients with a single lesion in native vessels and 164 in SVG, were followed for 5 years. Results. MI was more frequent in SVG (subdistributional hazard ratio (SHR) 4.95 (3.75 – 6.54, p<0.001), but not affected by stent type. In the first 500 days DES reduced TLR in native vessels (SHR 0.21 ( 0.15 – 0.30)p<0.001) and SVG (SHR 0.18 (0.04 – 0.80) p=0.02). Thereafter DES and BMS were equivalent in native vessels, but DES had a higher TLR rate than BMS in SVG (SHR 3.31 (1.23 – 8.94) p=0.02). After 5 years the TLR rate was still significantly lower for DES in native vessels (3.2 % versus 7.8 %, p<0.001) but not in SVG (21.4 % vs 18. 4%). Conclusion: In SVG no difference in TLR between DES and BMS was observed after 5 years in contrast to persistent benefit in native vessels. The high rate of TLR and myocardial infarction in SVG makes treatment of native vessels a preference whenever feasible and better treatment options for SVG are warranted.  

Drug-eluting versus bare-metal stents for treating saphenous vein grafts

2009 ◽  
Vol 158 (4) ◽  
pp. 637-643 ◽  
Author(s):  
Mehdi H. Shishehbor ◽  
Riem Hawi ◽  
Inder M. Singh ◽  
E. Murat Tuzcu ◽  
Deepak L. Bhatt ◽  
...  
Keyword(s):  
Saphenous Vein ◽  
Bare Metal Stents ◽  
Metal Stents ◽  
Bare Metal ◽  
Vein Grafts ◽  
Saphenous Vein Grafts ◽  
Drug Eluting
Sign in / Sign up

Export Citation Format

Share Document